Skip to Content

RELAFEN 750 (Relafen 750 mg)

Generic Name: nabumetone

Pill with imprint RELAFEN 750 is Beige, Elliptical / Oval and has been identified as Relafen 750 mg. It is supplied by GlaxoSmithKline.

Relafen is used in the treatment of osteoarthritis; rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Relafen 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RELAFEN 750

Relafen

Generic Name
nabumetone
Imprint
RELAFEN 750
Strength
750 mg
Color
Beige
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)
00029-4852

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.